SlideShare a Scribd company logo
1 of 57
March,2018
NANOPARTICLES
NEHA BHAMBOO
ASU2019010200056
M Pharm (2nd Sem.)
Submitted to: Dr. Anupama Diwan
1
CONTENT
• Introduction
• Advantages
• Properties
• Types
• Preparation
• Evaluation
2
NANOPARTICLE
INTRODUCTION:- nano derives from the Greek word “nanos”, which means
dwarf or extremely small.
• Nanoparticles are particles between 1-100 nanometers(nm) in size with a
surrounding interfacial layer.
• Nanoparticles are sub-nano ionized colloidal structures composed of
synthetic or semi-synthetic polymers”.
• The interfacial layer is an integral part of the nanoparticles, fundamentally
affecting all of its properties.
• The interfacial layer typically consists of ions, inorganic and organic
molecules.
• The drug is dissolved, entrapped, encapsulated or attached to a
nanoparticle matrix.
3
• Nanoparticles are not simple molecules itself and therefore composed of three
layers –
 The surface layer, which may be functionalized with a variety of small
molecules, metal ions, surfactants and polymers.
 The shell layer, which is chemically different material from the core in all
aspects.
 The core, which is essentially the central portion of the NP and usually refers
the NP itself.
4
Properties
• NPs possess unique physical and chemical properties due to their high surface
area and nanoscale size.
• Their optical properties are reported to be dependent on the size, which imparts
different colors due to absorption in the visible region their reactivity, toughness.
• The other properties are also dependent on their unique sizes, shape and
structure.
• Some of the important properties are:-
• Electronic and optical properties
• Magnetic properties
• Mechanical properties
• Thermal properties
5
TYPES
1) Carbon-based nanoparticles
2) Solid-lipid nanoparticles
3) Silicon-based nanoparticles
4) Liposomes
5) Nanosomes
6) Niosomes
7) Nanocrystals and nanosuspensions
6
1) Carbon based nanoparticles
• CNPs are elongated, tubular structure, 1–2 nm in
diameter. These are structurally resembling to
graphite sheet rolling upon itself
• The rolled sheets can be single, double or many
walls and therefore they named as single-walled
(SWNTs), double-walled (DWNTs) or multi-walled
carbon nanotubes (MWNTs), respectively.
• They are widely synthesized by deposition of
carbon precursors especially the atomic carbons,
vaporized from graphite by laser or by electric arc
on to metal particles.
7
Advantages
 High electrical conductivity
 High mechanical strength
 Ultra-light weight
 High thermal conductivity
 Metallic or semi-metallic behaviour
 High surface area
8
Applications
 Cell specifity
 Vaccine delivery
 Gene delivery
 Transport of peptides, nucleic acids and other drug molecules
 Reduced toxicity and increase the efficacy
 Gene silencing
 In diagnostics
9
2) Solid-lipid nanoparticles
• A solid-lipid NP is characteristically spherical
with diameter ranging from 10 to 1000 nm.
• Like polymeric NPs, these NPs possess a solid
core made of lipid and a matrix contains soluble
lipophilic molecules.
• Surfactants or emulsifiers stabilized the
external core of these NPs.
10
Advantages
Excellent biocompatibility
 Improve stability of pharmaceuticals
 High and enhanced drug content
 Easy to scale up and sterilize
 Enhanced bioavailability of entrapped bioactive compounds
 Chemical protection of labile incorporated compounds
11
Applications
 In cancer therapy
 In proteins & peptides delivery
 For targeted brain drug delivery
 For parasitic diseases
 Ultrasonic drug & gene delivery
 treatment of malaria
 dermatological preparations
 agriculture applications
12
3) Silicon based nanoparticles
• Silicon-based materials, porous silicon and silica, or
silicon dioxide are the most materials that are
architecture in form of calcified nano pores, platinum
materials containing nano pores, porous
nanoparticles, and nano needles.
• Nano pores size (diameter) and density can be
accurately controlled to achieve a constant drug
delivery rate through the pores.
13
Advantages
 It can have a higher mobility due to the presence of the silicon
crystallites.
 Higher dielectric constant then bulk silicon.
 One of the most important advantage of nano crystalline
silicon, however is that it has increased stability over a-Si.
14
Applications
 Act as an artificial growth factor
 For antibody delivery
 For antibiotics, enzymes and DNA delivery
15
4) Liposomes
• Liposomes are concentric bilayered vesicles in which an
aqueous core is entirely enclosed by a membranous lipid bilayer
mainly composed of natural or synthetic phospholipids.
• The size of a liposome ranges from some 20 nm up to several
micrometers.
• The lipid molecules are usually phospholipids- amphipathic
moieties with a hydrophilic head group and two hydrophobic
tails.
• On addition of excess water, such lipid moieties spontaneously
originate to give the most thermodynamically stable
conformation.
• In which polar head groups face outwards into the aqueous
medium, and the lipid chains turns inwards to avoid the water
phase, giving rise to double layer or bilayer lamellar structures.
16
Advantages
Provides selective passive targeting to tumor tissues.
Increased efficacy and therapeutic index.
Increased stability of encapsulated drug.
Reduction in toxicity of the encapsulated agent.
Site avoidance effect (avoids non-target tissues).
Improved pharmacokinetic effects (reduced elimination increased ci
rculation life times).
Flexibility to couple with site specific ligands to achieve active target
17
Applications
 Chelation therapy for treatment of heavy metal poisoning.
Liposomes as protein carriers in immunology
Sustained or controlled delivery
Diagnostic imaging of tumors
Intracellular drug delivery
Site-specific targeting
Enzyme replacement
Oral drug delivery
Gene therapeutics
18
5) Nanosomes
• Consist of one row of water heads and one row of fatty tails.
• They are therefore smaller than Liposomes and can (for cosmetic
purposes) penetrate to the Dermis.
• They are an excellent delivery system because as well as been able to
penetrate deep into the skin, they can resist the cells defence
systems but can nonetheless influence cell processes.
• Once having penetrated into the skin they can integrate themselves
into larger molecules.
• Just as with Liposomes they should only be used in and with products
that do not contain chemical preservatives, chemical sunscreens,
animal derivatives, fragrance and colorants as these unwelcome
elements will also be transported into the skin by the nanosomes and
may cause dermatitis, allergies, aging, hormonal disturbances, acne
and even cancer.
19
Advantages
 Nanosomes can easily penetrate into small blood vessels by
intravenous injection and into skin by topical application.
 Their entrapped material can be easily delivered targets such
as cells.
20
Applications
 Brain targeting:- These nanosomes are being developed for
treatment of various tumors (CNS tumors) e.g. silica coated
iron oxide nanoparticles coated with polyethylene glycol used
to access specific areas of brain involved with tumor
 Tumor targeting:- Nanosomal delivery with magnetic
resonance imaging and laser assist in targeting the
nanoparticle specifically to the tumor cells and destroy the
cells loaded with these nanoparticles by the heat generated by
iron oxide particles by absorbing the infra red light.
21
6) Niosomes
• Niosome is a class of molecular cluster formed by self-association of non-ionic
surfactants in an aqueous phase. They have ability of loading both hydrophilic and
lipophilic drugs.
• Niosomes are vesicles composed of non-ionic surfactants, which are biodegradable,
relatively nontoxic, more stable and inexpensive, an alternative to liposomes.
• Niosomes behave in vivo like liposomes, prolonging the circulation of entrapped
drug and altering its organ distribution and metabolic stability.
• It is reported that the intercalation of cholesterol in the bilayers decreases the
entrapment volume during formulation, and thus entrapment efficiency.
• However, differences in characteristics exist between liposomes and niosomes,
especially since niosomes are prepared from uncharged single-chain surfactant and
cholesterol, whereas liposomes are prepared from double- chain phospholipids
(neutral or charged).
• The concentration of cholesterol in liposomes is much more than that in niosomes.
As a result, drug entrapment efficiency of liposomes becomes lesser than niosomes
22
Advantages
They are osmotically active and stable.
They increase the stability of entrapped drug.
The vesicle suspension being water based offers greater patient
compliance over oil based systems
Since the structure of niosome offers place to accommodate
hydrophilic, lipophilic as a well as amphiphilic drug moieties, they
can be used for a variety of drugs.
The vesciles can act as a depot to release the drug slowly and of
controlled release
Biodegradable, non-immunogenic and biocompatible.
23
Applications
It is used as drug targeting
It is used as Anti-Neoplastic treatment i.e. cancer disease, eg.
Methotraxate
Used in Leishmaniasis i.e dermal and mucocutaneous infections eg.
sodium stibogluconate
 Used in delivery of peptide drugs
Niosomes as carriers for haemoglobin
It is used in ophthalmic drug delivery eg. Cyclopentane
Transdermal drug delivery system utilizing niosomes
eg.Erythromycine
24
7) Nanocrystals and nanosuspensions
 To produce Nanocrystals, the drug powder is dispersed in a surfactant
solution and the obtained suspension undergoes a pearl milling
process for hours upto several days.
 To produce Nanosuspensions, the drug is dispersed in an aqueous
surfactant solution by high speed stirring.
 The obtained macro-suspension is passed through a high speed
homogenizer leading to the formation of nanosuspension of the poorly
water-soluble drug.
25
Advantages
Improved bioavailability
Improved dose proportionality
Reduced variability
Enhanced absorption rate
26
Applications
It is used for targeting to the mucosa of the gastrointestinal
tract.
Targeting to the cells of nonnuclear phagocytic system(MPS) to
treat infections of MPS.
27
8) Hydrogel Nanoparticles
 Hydrogel nanoparticles are formed in water by
self-assemblage and self-aggregation of natural
polymer amphiphiles such as hydrophobized
polysaccharides, like cholesteroyl dextran .
 Cholestrol bearing polysaccharides (CHP) self-
aggregate to form a mono-disperse and stable
hydrogel nanoparticles, in which the domains of
the associated cholesterol groups of cholestoryl
polysaccharides provide cross-linking points In a
non-covalent manner.
 The size and density of hydrogel nanoparticles
can be controlled by changing the degree of
substitution of cholesterol groups of CHP.
28
Advantages
 Environment can protect cells and other substances (i.e.drugs,
proteins and peptides)
Timed release of growth factors and other nutrients to ensure
proper issue growth
Good transport properties
Biocompatible
Can be injected
Easy to modify
29
Applications
 Hydrogels are used for manufacturing contact lenses
 Hygiene products
 Tissue engineering scaffolds
 Drug delivery systems and wound dressings.
30
9) Copolymerized peptide nanoparticles
(CPP)
 A novel co polymeric nano particulate drug delivery system,
copolymerized peptide particles(CPP) has been developed as a carrier
for the oral uptake of therapeutic peptides.
 It is a drug polymer conjugate which forms its own nano particulate
delivery system in which drug moiety is covalently bound, rather
physically entrapped within the system.
31
Advantages
Enhance the oral uptake of peptides for drug delivery
Colloidal carriers can theoretically protect a labile drug from
degradation in the gut, and the systemic delivery of the drug
Enhance circulating half-life, Achieve drug targeting, is the
formation of a drug-polymer conjugate, e.g. conjugation of the
active drug moiety with polyethylene glycol .
32
Applications
Target drug delivery
Oral delivery of peptides
33
PREPARATION TECHNIQUES
The drug can either be entrapped within the reservoir or the
matrix or otherwise be absorbed on the surface of these
particulate systems.
The polymers are strictly structured to a nano metric size range
particle using appropriate methodologies.
34
35
PREPARATION TECHNIQUES OF
NANOPARTICLES
AMPHIPHILIC
MACROMOLECULAR
CROSS-LINKING
POLYMERIZATION
BASED METHODS
POLYMER
PRECIPITATION
METHODS
HEAT CROSS-LINKING
CHEMICAL CROSS-LINKING
POLYMERZIATION OF MONOMERS
EMULSION POLYMERIZATION
DISPERSION POLYMERIZATION
INTERFACIAL CONDENSATION
POLYMERIZATION
INTERFACIAL COMPLEXATION
SOLVENT EXTRACTION
SOLVENT DISPLACEMENT
SALTING OUT
AMPHIPHILIC MACROMOLECULE CROSS-LINKING
 Nanoparticles can be prepared from amphiphilic macromolecules, proteins
and polysaccharides.
 The technique of their preparation involves :-
1. The aggregation of amphiphile
2. Stabilization by heat denaturation or by chemical cross-linking
These processes may occur in a biphasic O/W or W/O type dispersed
systems, which subdivide the amphiphile prior to aggregative stabilization.
It may also takes place in an aqueous amphiphilic solution where on
removal, extraction, or diffusion of solvent, amphiphiles are aggregated as
tiny particulates and subsequently rigidized via chemical cross-linking.
The cross-linking generally executed following dispersed phase solvent
extraction or depletion.
36
37
Heat cross-linking method
Aqueous
protein(BSA)
Oil
Surfactant
O/W emulsion
Dilution with a preheated (at 100°C) oil
(heat cross-linking) or addition of cross-
linking agent(chemical cross-linking)
Centrifugation and isolation of
nanoparticles
POLYMERIZATION BASED METHODS
 Two different approaches are generally adopted for the
preparation of nano spheres using in situ polymerization
technique:-
1. Methods in which the monomer to be polymerized is
emulsified in a non-solvent phase (emulsion polymerization).
2. Methods in which the monomer is dissolved in a solvent that is
non-solvent for the resulting polymer (dispersion
polymerization).
38
39
1. Interfacial polymer condensation
Core phase + Drug Polymer phase
Core dispersed in polymer
in polymer phase
(O/W emulsion)
Non-solvent, which precipitate out
polymer from either of phases
Nanocapsules (30-300nm)
40
2. Interfacial polymerization
Water + Monomer A Oil phase
Monomer
A
High pressure homogenization
W/O emulsion
Monomer B
Nanocapsules
POLYMER PRECIPITATION METHODS
 In these methods, the hydrophobic polymer or a hydrophobic drug is dissolved
in a particular organic solvent followed by its dispersion in a continuous aqueous
phase, in which the polymer is insoluble.
 The external phase also contains the stabilizer.
 The polymer precipitation occurs as a consequence of the solvent extraction or
evaporation, which can be brought about by:-
 Increasing the solubility of the organic solvent in the external medium by adding
an alcohol(i.e. isopropanol)
 By incorporating additional amount water into the ultra emulsion
 By evaporation of the organic solvent at room temperature or at accelerated
temperatures or by using vacuum
 Using an organic solvent that is completely soluble in the continuous aqueous
phase-nanoprecipitation.
41
42
1. Solvent extraction method
Organic phase solvent,
Drug, Polymer
Aqueous phase
Distilled water,
stabilizer
Sonication, homogenization
O/W emulsion
Solvent extraction, solvent
evaporation
43
2. Solvent Displacement Method
Distilled water
Polaxamer 188
Distilled water
Polaxamer 188
Organic solvent
Polymer, Drug
Polar solvent, Oil,
Polymer, Drug
Aqueous phase Aqueous phase
Magnetic
stirring
Nanospheres Nanocapsules
Organic phase Organic phase
44
3. Salting out of Polymer
Organic solvent,
Drug, Polymer
Distilled water,
PVA, MgCl2
Organic phase Aqueous phase
Distilled water
O/W emulsion
Mechanical
stirring
EVALUATION
1. Particle size
2. Density
3. Molecular weight
4. Structure and crystallinity
5. Specific surface area
6. Surface charge & electronic mobility
7. Surface hydrophobicity
8. In-vitro release
9. Nanoparticle yield
10.Drug entrapment efficiency
45
1. Particle size
Two main techniques are used to determine the particle size of
nanoparticles.
Photon correlation spectroscopy
Electron microscopy
1)scanning electron microscopy
2)transmission electron microscope
3)freeze fracture techniques
46
Photon correlation spectroscopy (PCS): for smaller particles
Laser diffractrometry: for larger particles
Electron microscopy (EM): required coating of conductive
material such as gold & limited to dry sample
Transmission electron microscopy (TEM): easier method &
permits differentiation among nanocapsule & nanoparticle.
47
2. Density
The density of nanoparticles is determined with helium or
using a gas pycnometer .
The value obtained with air and with helium may differ from
each other.
48
3. Molecular weight
It is determined by using GEL PERMEATION
CHROMATOGRAPHY using refractive index
detector.
49
4. Structure and crystallinity
 X-Ray Diffraction method
 Thermo analytical methods:-
1.Differential scanning colorimetry
2.Differential thermal analysis
3.Thermo gravimetry
50
5. Specific surface area
 It is determined by Sorptometer
 The specific surface area of freeze dried nanoparticles is
measured using Sorptometer.
The residual surfactant reduces the specific surface area.
51
6. Surface charge & electronic mobility
 Surface charge of particle can be determined by measuring particle
velocity in electrical field.
 Laser Doppler Anemometry technique for determination of
nanoparticles velocity.
 Surface charge is also measured as electrical mobility.
 Charged composition critically decides bio-distribution of nanoparticle.
 Zeta potential can also be obtain by measuring the electron mobility.
52
7. Surface hydrophobicity
Important influence in interaction of nanoparticles with
biological environment.
Several methods have been used
1. Hydrophobic interaction chromatography.
2. Two phase partition
3. Contact angle measurement.
53
8. in-vitro release
 in-vitro release studies are done by:
1. Diffusion cell
2. Ultra- filteration technique
54
9. Nanoparticle yield
55
10. Drug entrapment efficiency
56
57

More Related Content

What's hot

nanotechnology in drug delivery and diagnostic
nanotechnology in drug delivery and diagnostic nanotechnology in drug delivery and diagnostic
nanotechnology in drug delivery and diagnostic
Saurabh Sharma
 

What's hot (20)

NANOPARTICULATE DRUG DELIVERY SYSTEM
NANOPARTICULATE DRUG DELIVERY SYSTEMNANOPARTICULATE DRUG DELIVERY SYSTEM
NANOPARTICULATE DRUG DELIVERY SYSTEM
 
Nano Particles for Drug Delivery
Nano Particles for Drug DeliveryNano Particles for Drug Delivery
Nano Particles for Drug Delivery
 
Nanoparticulate drug delivery system : recent advances
Nanoparticulate drug delivery system : recent advancesNanoparticulate drug delivery system : recent advances
Nanoparticulate drug delivery system : recent advances
 
Nanoparticle
NanoparticleNanoparticle
Nanoparticle
 
Nanomaterials in Drug Delivery
Nanomaterials in Drug DeliveryNanomaterials in Drug Delivery
Nanomaterials in Drug Delivery
 
Nanoparticles ppt
Nanoparticles pptNanoparticles ppt
Nanoparticles ppt
 
Drug delivery via nanocapsules
Drug delivery via nanocapsules Drug delivery via nanocapsules
Drug delivery via nanocapsules
 
Nanoparticles
NanoparticlesNanoparticles
Nanoparticles
 
nanoparticles
 nanoparticles nanoparticles
nanoparticles
 
Application of nanoparticals in drug delivery system
Application of nanoparticals in drug delivery systemApplication of nanoparticals in drug delivery system
Application of nanoparticals in drug delivery system
 
Polymeric nanoparticles A Novel Approach
Polymeric nanoparticles  A Novel ApproachPolymeric nanoparticles  A Novel Approach
Polymeric nanoparticles A Novel Approach
 
Pr esent ation of nanoparticle
Pr esent ation of nanoparticlePr esent ation of nanoparticle
Pr esent ation of nanoparticle
 
Nanotechnology Based Drug Delivery
Nanotechnology Based Drug DeliveryNanotechnology Based Drug Delivery
Nanotechnology Based Drug Delivery
 
Presentation on nanoparticles
Presentation on nanoparticlesPresentation on nanoparticles
Presentation on nanoparticles
 
Nanoparticles
Nanoparticles Nanoparticles
Nanoparticles
 
Solid lipid nanoparticles
Solid lipid nanoparticlesSolid lipid nanoparticles
Solid lipid nanoparticles
 
Bilosomes and emulsomes.pptx
Bilosomes and emulsomes.pptxBilosomes and emulsomes.pptx
Bilosomes and emulsomes.pptx
 
Nanoparticles for Cancer Therapy
Nanoparticles for Cancer TherapyNanoparticles for Cancer Therapy
Nanoparticles for Cancer Therapy
 
nanotechnology in drug delivery and diagnostic
nanotechnology in drug delivery and diagnostic nanotechnology in drug delivery and diagnostic
nanotechnology in drug delivery and diagnostic
 
Nanoparticle for drug delivery system
Nanoparticle for drug delivery systemNanoparticle for drug delivery system
Nanoparticle for drug delivery system
 

Similar to Neha (m pharm) nanoparticle

nanoparticulatedrugdeliverysysytemchatap-160529060436.pdf
nanoparticulatedrugdeliverysysytemchatap-160529060436.pdfnanoparticulatedrugdeliverysysytemchatap-160529060436.pdf
nanoparticulatedrugdeliverysysytemchatap-160529060436.pdf
vandanatyagi25
 
Nanoparticulate drug delivery sysytem
Nanoparticulate drug delivery sysytem Nanoparticulate drug delivery sysytem
Nanoparticulate drug delivery sysytem
Pravin Chinchole
 

Similar to Neha (m pharm) nanoparticle (20)

liposomes and nanoparticles drug delivery system
liposomes and nanoparticles drug delivery systemliposomes and nanoparticles drug delivery system
liposomes and nanoparticles drug delivery system
 
nanoparticulatedrugdeliverysysytemchatap-160529060436.pdf
nanoparticulatedrugdeliverysysytemchatap-160529060436.pdfnanoparticulatedrugdeliverysysytemchatap-160529060436.pdf
nanoparticulatedrugdeliverysysytemchatap-160529060436.pdf
 
Nanoparticulate drug delivery sysytem
Nanoparticulate drug delivery sysytem Nanoparticulate drug delivery sysytem
Nanoparticulate drug delivery sysytem
 
Nanopharmacology
Nanopharmacology Nanopharmacology
Nanopharmacology
 
Nanotechnology as a dds by pradipkumar rathod
Nanotechnology as a dds by pradipkumar rathodNanotechnology as a dds by pradipkumar rathod
Nanotechnology as a dds by pradipkumar rathod
 
Niosomes Naveen Balaji
Niosomes Naveen BalajiNiosomes Naveen Balaji
Niosomes Naveen Balaji
 
Nanoparticles and their medical applications
Nanoparticles and their medical applicationsNanoparticles and their medical applications
Nanoparticles and their medical applications
 
MUDASIR MALIK
MUDASIR MALIKMUDASIR MALIK
MUDASIR MALIK
 
Niosome ndds- By Ankita Rai
Niosome   ndds- By Ankita RaiNiosome   ndds- By Ankita Rai
Niosome ndds- By Ankita Rai
 
Niosome
Niosome Niosome
Niosome
 
application of nanaocarriers in delivery of biotechnologicals
application of nanaocarriers in delivery of biotechnologicalsapplication of nanaocarriers in delivery of biotechnologicals
application of nanaocarriers in delivery of biotechnologicals
 
liposome mediated gene delivery
liposome mediated gene deliveryliposome mediated gene delivery
liposome mediated gene delivery
 
Novel drug delivery system
Novel drug delivery systemNovel drug delivery system
Novel drug delivery system
 
NANOSYSTEMS - Vesicles, Liposomes, Polymeric micelles & Dendrimers
NANOSYSTEMS - Vesicles, Liposomes, Polymeric micelles & DendrimersNANOSYSTEMS - Vesicles, Liposomes, Polymeric micelles & Dendrimers
NANOSYSTEMS - Vesicles, Liposomes, Polymeric micelles & Dendrimers
 
Solid lipid nanoparticles
Solid lipid nanoparticlesSolid lipid nanoparticles
Solid lipid nanoparticles
 
Targeting methods nanoparticles dr. asm
Targeting methods nanoparticles dr. asmTargeting methods nanoparticles dr. asm
Targeting methods nanoparticles dr. asm
 
Nanotechnoloy in Cancer.pptx
Nanotechnoloy in Cancer.pptxNanotechnoloy in Cancer.pptx
Nanotechnoloy in Cancer.pptx
 
sterile product and formulation technology presentation
sterile product and formulation technology presentationsterile product and formulation technology presentation
sterile product and formulation technology presentation
 
nanotechnology.pptx
nanotechnology.pptxnanotechnology.pptx
nanotechnology.pptx
 
Liposomes & Niosomes.pptx
Liposomes & Niosomes.pptxLiposomes & Niosomes.pptx
Liposomes & Niosomes.pptx
 

Recently uploaded

1029-Danh muc Sach Giao Khoa khoi 6.pdf
1029-Danh muc Sach Giao Khoa khoi  6.pdf1029-Danh muc Sach Giao Khoa khoi  6.pdf
1029-Danh muc Sach Giao Khoa khoi 6.pdf
QucHHunhnh
 
Gardella_Mateo_IntellectualProperty.pdf.
Gardella_Mateo_IntellectualProperty.pdf.Gardella_Mateo_IntellectualProperty.pdf.
Gardella_Mateo_IntellectualProperty.pdf.
MateoGardella
 
1029 - Danh muc Sach Giao Khoa 10 . pdf
1029 -  Danh muc Sach Giao Khoa 10 . pdf1029 -  Danh muc Sach Giao Khoa 10 . pdf
1029 - Danh muc Sach Giao Khoa 10 . pdf
QucHHunhnh
 
Beyond the EU: DORA and NIS 2 Directive's Global Impact
Beyond the EU: DORA and NIS 2 Directive's Global ImpactBeyond the EU: DORA and NIS 2 Directive's Global Impact
Beyond the EU: DORA and NIS 2 Directive's Global Impact
PECB
 
Activity 01 - Artificial Culture (1).pdf
Activity 01 - Artificial Culture (1).pdfActivity 01 - Artificial Culture (1).pdf
Activity 01 - Artificial Culture (1).pdf
ciinovamais
 
Gardella_PRCampaignConclusion Pitch Letter
Gardella_PRCampaignConclusion Pitch LetterGardella_PRCampaignConclusion Pitch Letter
Gardella_PRCampaignConclusion Pitch Letter
MateoGardella
 
Making and Justifying Mathematical Decisions.pdf
Making and Justifying Mathematical Decisions.pdfMaking and Justifying Mathematical Decisions.pdf
Making and Justifying Mathematical Decisions.pdf
Chris Hunter
 
An Overview of Mutual Funds Bcom Project.pdf
An Overview of Mutual Funds Bcom Project.pdfAn Overview of Mutual Funds Bcom Project.pdf
An Overview of Mutual Funds Bcom Project.pdf
SanaAli374401
 

Recently uploaded (20)

Mattingly "AI & Prompt Design: The Basics of Prompt Design"
Mattingly "AI & Prompt Design: The Basics of Prompt Design"Mattingly "AI & Prompt Design: The Basics of Prompt Design"
Mattingly "AI & Prompt Design: The Basics of Prompt Design"
 
1029-Danh muc Sach Giao Khoa khoi 6.pdf
1029-Danh muc Sach Giao Khoa khoi  6.pdf1029-Danh muc Sach Giao Khoa khoi  6.pdf
1029-Danh muc Sach Giao Khoa khoi 6.pdf
 
Mattingly "AI & Prompt Design: Structured Data, Assistants, & RAG"
Mattingly "AI & Prompt Design: Structured Data, Assistants, & RAG"Mattingly "AI & Prompt Design: Structured Data, Assistants, & RAG"
Mattingly "AI & Prompt Design: Structured Data, Assistants, & RAG"
 
Gardella_Mateo_IntellectualProperty.pdf.
Gardella_Mateo_IntellectualProperty.pdf.Gardella_Mateo_IntellectualProperty.pdf.
Gardella_Mateo_IntellectualProperty.pdf.
 
1029 - Danh muc Sach Giao Khoa 10 . pdf
1029 -  Danh muc Sach Giao Khoa 10 . pdf1029 -  Danh muc Sach Giao Khoa 10 . pdf
1029 - Danh muc Sach Giao Khoa 10 . pdf
 
Application orientated numerical on hev.ppt
Application orientated numerical on hev.pptApplication orientated numerical on hev.ppt
Application orientated numerical on hev.ppt
 
Introduction to Nonprofit Accounting: The Basics
Introduction to Nonprofit Accounting: The BasicsIntroduction to Nonprofit Accounting: The Basics
Introduction to Nonprofit Accounting: The Basics
 
PROCESS RECORDING FORMAT.docx
PROCESS      RECORDING        FORMAT.docxPROCESS      RECORDING        FORMAT.docx
PROCESS RECORDING FORMAT.docx
 
Basic Civil Engineering first year Notes- Chapter 4 Building.pptx
Basic Civil Engineering first year Notes- Chapter 4 Building.pptxBasic Civil Engineering first year Notes- Chapter 4 Building.pptx
Basic Civil Engineering first year Notes- Chapter 4 Building.pptx
 
microwave assisted reaction. General introduction
microwave assisted reaction. General introductionmicrowave assisted reaction. General introduction
microwave assisted reaction. General introduction
 
SECOND SEMESTER TOPIC COVERAGE SY 2023-2024 Trends, Networks, and Critical Th...
SECOND SEMESTER TOPIC COVERAGE SY 2023-2024 Trends, Networks, and Critical Th...SECOND SEMESTER TOPIC COVERAGE SY 2023-2024 Trends, Networks, and Critical Th...
SECOND SEMESTER TOPIC COVERAGE SY 2023-2024 Trends, Networks, and Critical Th...
 
Mehran University Newsletter Vol-X, Issue-I, 2024
Mehran University Newsletter Vol-X, Issue-I, 2024Mehran University Newsletter Vol-X, Issue-I, 2024
Mehran University Newsletter Vol-X, Issue-I, 2024
 
Beyond the EU: DORA and NIS 2 Directive's Global Impact
Beyond the EU: DORA and NIS 2 Directive's Global ImpactBeyond the EU: DORA and NIS 2 Directive's Global Impact
Beyond the EU: DORA and NIS 2 Directive's Global Impact
 
Activity 01 - Artificial Culture (1).pdf
Activity 01 - Artificial Culture (1).pdfActivity 01 - Artificial Culture (1).pdf
Activity 01 - Artificial Culture (1).pdf
 
Gardella_PRCampaignConclusion Pitch Letter
Gardella_PRCampaignConclusion Pitch LetterGardella_PRCampaignConclusion Pitch Letter
Gardella_PRCampaignConclusion Pitch Letter
 
Making and Justifying Mathematical Decisions.pdf
Making and Justifying Mathematical Decisions.pdfMaking and Justifying Mathematical Decisions.pdf
Making and Justifying Mathematical Decisions.pdf
 
APM Welcome, APM North West Network Conference, Synergies Across Sectors
APM Welcome, APM North West Network Conference, Synergies Across SectorsAPM Welcome, APM North West Network Conference, Synergies Across Sectors
APM Welcome, APM North West Network Conference, Synergies Across Sectors
 
Presentation by Andreas Schleicher Tackling the School Absenteeism Crisis 30 ...
Presentation by Andreas Schleicher Tackling the School Absenteeism Crisis 30 ...Presentation by Andreas Schleicher Tackling the School Absenteeism Crisis 30 ...
Presentation by Andreas Schleicher Tackling the School Absenteeism Crisis 30 ...
 
An Overview of Mutual Funds Bcom Project.pdf
An Overview of Mutual Funds Bcom Project.pdfAn Overview of Mutual Funds Bcom Project.pdf
An Overview of Mutual Funds Bcom Project.pdf
 
Explore beautiful and ugly buildings. Mathematics helps us create beautiful d...
Explore beautiful and ugly buildings. Mathematics helps us create beautiful d...Explore beautiful and ugly buildings. Mathematics helps us create beautiful d...
Explore beautiful and ugly buildings. Mathematics helps us create beautiful d...
 

Neha (m pharm) nanoparticle

  • 1. March,2018 NANOPARTICLES NEHA BHAMBOO ASU2019010200056 M Pharm (2nd Sem.) Submitted to: Dr. Anupama Diwan 1
  • 2. CONTENT • Introduction • Advantages • Properties • Types • Preparation • Evaluation 2
  • 3. NANOPARTICLE INTRODUCTION:- nano derives from the Greek word “nanos”, which means dwarf or extremely small. • Nanoparticles are particles between 1-100 nanometers(nm) in size with a surrounding interfacial layer. • Nanoparticles are sub-nano ionized colloidal structures composed of synthetic or semi-synthetic polymers”. • The interfacial layer is an integral part of the nanoparticles, fundamentally affecting all of its properties. • The interfacial layer typically consists of ions, inorganic and organic molecules. • The drug is dissolved, entrapped, encapsulated or attached to a nanoparticle matrix. 3
  • 4. • Nanoparticles are not simple molecules itself and therefore composed of three layers –  The surface layer, which may be functionalized with a variety of small molecules, metal ions, surfactants and polymers.  The shell layer, which is chemically different material from the core in all aspects.  The core, which is essentially the central portion of the NP and usually refers the NP itself. 4
  • 5. Properties • NPs possess unique physical and chemical properties due to their high surface area and nanoscale size. • Their optical properties are reported to be dependent on the size, which imparts different colors due to absorption in the visible region their reactivity, toughness. • The other properties are also dependent on their unique sizes, shape and structure. • Some of the important properties are:- • Electronic and optical properties • Magnetic properties • Mechanical properties • Thermal properties 5
  • 6. TYPES 1) Carbon-based nanoparticles 2) Solid-lipid nanoparticles 3) Silicon-based nanoparticles 4) Liposomes 5) Nanosomes 6) Niosomes 7) Nanocrystals and nanosuspensions 6
  • 7. 1) Carbon based nanoparticles • CNPs are elongated, tubular structure, 1–2 nm in diameter. These are structurally resembling to graphite sheet rolling upon itself • The rolled sheets can be single, double or many walls and therefore they named as single-walled (SWNTs), double-walled (DWNTs) or multi-walled carbon nanotubes (MWNTs), respectively. • They are widely synthesized by deposition of carbon precursors especially the atomic carbons, vaporized from graphite by laser or by electric arc on to metal particles. 7
  • 8. Advantages  High electrical conductivity  High mechanical strength  Ultra-light weight  High thermal conductivity  Metallic or semi-metallic behaviour  High surface area 8
  • 9. Applications  Cell specifity  Vaccine delivery  Gene delivery  Transport of peptides, nucleic acids and other drug molecules  Reduced toxicity and increase the efficacy  Gene silencing  In diagnostics 9
  • 10. 2) Solid-lipid nanoparticles • A solid-lipid NP is characteristically spherical with diameter ranging from 10 to 1000 nm. • Like polymeric NPs, these NPs possess a solid core made of lipid and a matrix contains soluble lipophilic molecules. • Surfactants or emulsifiers stabilized the external core of these NPs. 10
  • 11. Advantages Excellent biocompatibility  Improve stability of pharmaceuticals  High and enhanced drug content  Easy to scale up and sterilize  Enhanced bioavailability of entrapped bioactive compounds  Chemical protection of labile incorporated compounds 11
  • 12. Applications  In cancer therapy  In proteins & peptides delivery  For targeted brain drug delivery  For parasitic diseases  Ultrasonic drug & gene delivery  treatment of malaria  dermatological preparations  agriculture applications 12
  • 13. 3) Silicon based nanoparticles • Silicon-based materials, porous silicon and silica, or silicon dioxide are the most materials that are architecture in form of calcified nano pores, platinum materials containing nano pores, porous nanoparticles, and nano needles. • Nano pores size (diameter) and density can be accurately controlled to achieve a constant drug delivery rate through the pores. 13
  • 14. Advantages  It can have a higher mobility due to the presence of the silicon crystallites.  Higher dielectric constant then bulk silicon.  One of the most important advantage of nano crystalline silicon, however is that it has increased stability over a-Si. 14
  • 15. Applications  Act as an artificial growth factor  For antibody delivery  For antibiotics, enzymes and DNA delivery 15
  • 16. 4) Liposomes • Liposomes are concentric bilayered vesicles in which an aqueous core is entirely enclosed by a membranous lipid bilayer mainly composed of natural or synthetic phospholipids. • The size of a liposome ranges from some 20 nm up to several micrometers. • The lipid molecules are usually phospholipids- amphipathic moieties with a hydrophilic head group and two hydrophobic tails. • On addition of excess water, such lipid moieties spontaneously originate to give the most thermodynamically stable conformation. • In which polar head groups face outwards into the aqueous medium, and the lipid chains turns inwards to avoid the water phase, giving rise to double layer or bilayer lamellar structures. 16
  • 17. Advantages Provides selective passive targeting to tumor tissues. Increased efficacy and therapeutic index. Increased stability of encapsulated drug. Reduction in toxicity of the encapsulated agent. Site avoidance effect (avoids non-target tissues). Improved pharmacokinetic effects (reduced elimination increased ci rculation life times). Flexibility to couple with site specific ligands to achieve active target 17
  • 18. Applications  Chelation therapy for treatment of heavy metal poisoning. Liposomes as protein carriers in immunology Sustained or controlled delivery Diagnostic imaging of tumors Intracellular drug delivery Site-specific targeting Enzyme replacement Oral drug delivery Gene therapeutics 18
  • 19. 5) Nanosomes • Consist of one row of water heads and one row of fatty tails. • They are therefore smaller than Liposomes and can (for cosmetic purposes) penetrate to the Dermis. • They are an excellent delivery system because as well as been able to penetrate deep into the skin, they can resist the cells defence systems but can nonetheless influence cell processes. • Once having penetrated into the skin they can integrate themselves into larger molecules. • Just as with Liposomes they should only be used in and with products that do not contain chemical preservatives, chemical sunscreens, animal derivatives, fragrance and colorants as these unwelcome elements will also be transported into the skin by the nanosomes and may cause dermatitis, allergies, aging, hormonal disturbances, acne and even cancer. 19
  • 20. Advantages  Nanosomes can easily penetrate into small blood vessels by intravenous injection and into skin by topical application.  Their entrapped material can be easily delivered targets such as cells. 20
  • 21. Applications  Brain targeting:- These nanosomes are being developed for treatment of various tumors (CNS tumors) e.g. silica coated iron oxide nanoparticles coated with polyethylene glycol used to access specific areas of brain involved with tumor  Tumor targeting:- Nanosomal delivery with magnetic resonance imaging and laser assist in targeting the nanoparticle specifically to the tumor cells and destroy the cells loaded with these nanoparticles by the heat generated by iron oxide particles by absorbing the infra red light. 21
  • 22. 6) Niosomes • Niosome is a class of molecular cluster formed by self-association of non-ionic surfactants in an aqueous phase. They have ability of loading both hydrophilic and lipophilic drugs. • Niosomes are vesicles composed of non-ionic surfactants, which are biodegradable, relatively nontoxic, more stable and inexpensive, an alternative to liposomes. • Niosomes behave in vivo like liposomes, prolonging the circulation of entrapped drug and altering its organ distribution and metabolic stability. • It is reported that the intercalation of cholesterol in the bilayers decreases the entrapment volume during formulation, and thus entrapment efficiency. • However, differences in characteristics exist between liposomes and niosomes, especially since niosomes are prepared from uncharged single-chain surfactant and cholesterol, whereas liposomes are prepared from double- chain phospholipids (neutral or charged). • The concentration of cholesterol in liposomes is much more than that in niosomes. As a result, drug entrapment efficiency of liposomes becomes lesser than niosomes 22
  • 23. Advantages They are osmotically active and stable. They increase the stability of entrapped drug. The vesicle suspension being water based offers greater patient compliance over oil based systems Since the structure of niosome offers place to accommodate hydrophilic, lipophilic as a well as amphiphilic drug moieties, they can be used for a variety of drugs. The vesciles can act as a depot to release the drug slowly and of controlled release Biodegradable, non-immunogenic and biocompatible. 23
  • 24. Applications It is used as drug targeting It is used as Anti-Neoplastic treatment i.e. cancer disease, eg. Methotraxate Used in Leishmaniasis i.e dermal and mucocutaneous infections eg. sodium stibogluconate  Used in delivery of peptide drugs Niosomes as carriers for haemoglobin It is used in ophthalmic drug delivery eg. Cyclopentane Transdermal drug delivery system utilizing niosomes eg.Erythromycine 24
  • 25. 7) Nanocrystals and nanosuspensions  To produce Nanocrystals, the drug powder is dispersed in a surfactant solution and the obtained suspension undergoes a pearl milling process for hours upto several days.  To produce Nanosuspensions, the drug is dispersed in an aqueous surfactant solution by high speed stirring.  The obtained macro-suspension is passed through a high speed homogenizer leading to the formation of nanosuspension of the poorly water-soluble drug. 25
  • 26. Advantages Improved bioavailability Improved dose proportionality Reduced variability Enhanced absorption rate 26
  • 27. Applications It is used for targeting to the mucosa of the gastrointestinal tract. Targeting to the cells of nonnuclear phagocytic system(MPS) to treat infections of MPS. 27
  • 28. 8) Hydrogel Nanoparticles  Hydrogel nanoparticles are formed in water by self-assemblage and self-aggregation of natural polymer amphiphiles such as hydrophobized polysaccharides, like cholesteroyl dextran .  Cholestrol bearing polysaccharides (CHP) self- aggregate to form a mono-disperse and stable hydrogel nanoparticles, in which the domains of the associated cholesterol groups of cholestoryl polysaccharides provide cross-linking points In a non-covalent manner.  The size and density of hydrogel nanoparticles can be controlled by changing the degree of substitution of cholesterol groups of CHP. 28
  • 29. Advantages  Environment can protect cells and other substances (i.e.drugs, proteins and peptides) Timed release of growth factors and other nutrients to ensure proper issue growth Good transport properties Biocompatible Can be injected Easy to modify 29
  • 30. Applications  Hydrogels are used for manufacturing contact lenses  Hygiene products  Tissue engineering scaffolds  Drug delivery systems and wound dressings. 30
  • 31. 9) Copolymerized peptide nanoparticles (CPP)  A novel co polymeric nano particulate drug delivery system, copolymerized peptide particles(CPP) has been developed as a carrier for the oral uptake of therapeutic peptides.  It is a drug polymer conjugate which forms its own nano particulate delivery system in which drug moiety is covalently bound, rather physically entrapped within the system. 31
  • 32. Advantages Enhance the oral uptake of peptides for drug delivery Colloidal carriers can theoretically protect a labile drug from degradation in the gut, and the systemic delivery of the drug Enhance circulating half-life, Achieve drug targeting, is the formation of a drug-polymer conjugate, e.g. conjugation of the active drug moiety with polyethylene glycol . 32
  • 34. PREPARATION TECHNIQUES The drug can either be entrapped within the reservoir or the matrix or otherwise be absorbed on the surface of these particulate systems. The polymers are strictly structured to a nano metric size range particle using appropriate methodologies. 34
  • 35. 35 PREPARATION TECHNIQUES OF NANOPARTICLES AMPHIPHILIC MACROMOLECULAR CROSS-LINKING POLYMERIZATION BASED METHODS POLYMER PRECIPITATION METHODS HEAT CROSS-LINKING CHEMICAL CROSS-LINKING POLYMERZIATION OF MONOMERS EMULSION POLYMERIZATION DISPERSION POLYMERIZATION INTERFACIAL CONDENSATION POLYMERIZATION INTERFACIAL COMPLEXATION SOLVENT EXTRACTION SOLVENT DISPLACEMENT SALTING OUT
  • 36. AMPHIPHILIC MACROMOLECULE CROSS-LINKING  Nanoparticles can be prepared from amphiphilic macromolecules, proteins and polysaccharides.  The technique of their preparation involves :- 1. The aggregation of amphiphile 2. Stabilization by heat denaturation or by chemical cross-linking These processes may occur in a biphasic O/W or W/O type dispersed systems, which subdivide the amphiphile prior to aggregative stabilization. It may also takes place in an aqueous amphiphilic solution where on removal, extraction, or diffusion of solvent, amphiphiles are aggregated as tiny particulates and subsequently rigidized via chemical cross-linking. The cross-linking generally executed following dispersed phase solvent extraction or depletion. 36
  • 37. 37 Heat cross-linking method Aqueous protein(BSA) Oil Surfactant O/W emulsion Dilution with a preheated (at 100°C) oil (heat cross-linking) or addition of cross- linking agent(chemical cross-linking) Centrifugation and isolation of nanoparticles
  • 38. POLYMERIZATION BASED METHODS  Two different approaches are generally adopted for the preparation of nano spheres using in situ polymerization technique:- 1. Methods in which the monomer to be polymerized is emulsified in a non-solvent phase (emulsion polymerization). 2. Methods in which the monomer is dissolved in a solvent that is non-solvent for the resulting polymer (dispersion polymerization). 38
  • 39. 39 1. Interfacial polymer condensation Core phase + Drug Polymer phase Core dispersed in polymer in polymer phase (O/W emulsion) Non-solvent, which precipitate out polymer from either of phases Nanocapsules (30-300nm)
  • 40. 40 2. Interfacial polymerization Water + Monomer A Oil phase Monomer A High pressure homogenization W/O emulsion Monomer B Nanocapsules
  • 41. POLYMER PRECIPITATION METHODS  In these methods, the hydrophobic polymer or a hydrophobic drug is dissolved in a particular organic solvent followed by its dispersion in a continuous aqueous phase, in which the polymer is insoluble.  The external phase also contains the stabilizer.  The polymer precipitation occurs as a consequence of the solvent extraction or evaporation, which can be brought about by:-  Increasing the solubility of the organic solvent in the external medium by adding an alcohol(i.e. isopropanol)  By incorporating additional amount water into the ultra emulsion  By evaporation of the organic solvent at room temperature or at accelerated temperatures or by using vacuum  Using an organic solvent that is completely soluble in the continuous aqueous phase-nanoprecipitation. 41
  • 42. 42 1. Solvent extraction method Organic phase solvent, Drug, Polymer Aqueous phase Distilled water, stabilizer Sonication, homogenization O/W emulsion Solvent extraction, solvent evaporation
  • 43. 43 2. Solvent Displacement Method Distilled water Polaxamer 188 Distilled water Polaxamer 188 Organic solvent Polymer, Drug Polar solvent, Oil, Polymer, Drug Aqueous phase Aqueous phase Magnetic stirring Nanospheres Nanocapsules Organic phase Organic phase
  • 44. 44 3. Salting out of Polymer Organic solvent, Drug, Polymer Distilled water, PVA, MgCl2 Organic phase Aqueous phase Distilled water O/W emulsion Mechanical stirring
  • 45. EVALUATION 1. Particle size 2. Density 3. Molecular weight 4. Structure and crystallinity 5. Specific surface area 6. Surface charge & electronic mobility 7. Surface hydrophobicity 8. In-vitro release 9. Nanoparticle yield 10.Drug entrapment efficiency 45
  • 46. 1. Particle size Two main techniques are used to determine the particle size of nanoparticles. Photon correlation spectroscopy Electron microscopy 1)scanning electron microscopy 2)transmission electron microscope 3)freeze fracture techniques 46
  • 47. Photon correlation spectroscopy (PCS): for smaller particles Laser diffractrometry: for larger particles Electron microscopy (EM): required coating of conductive material such as gold & limited to dry sample Transmission electron microscopy (TEM): easier method & permits differentiation among nanocapsule & nanoparticle. 47
  • 48. 2. Density The density of nanoparticles is determined with helium or using a gas pycnometer . The value obtained with air and with helium may differ from each other. 48
  • 49. 3. Molecular weight It is determined by using GEL PERMEATION CHROMATOGRAPHY using refractive index detector. 49
  • 50. 4. Structure and crystallinity  X-Ray Diffraction method  Thermo analytical methods:- 1.Differential scanning colorimetry 2.Differential thermal analysis 3.Thermo gravimetry 50
  • 51. 5. Specific surface area  It is determined by Sorptometer  The specific surface area of freeze dried nanoparticles is measured using Sorptometer. The residual surfactant reduces the specific surface area. 51
  • 52. 6. Surface charge & electronic mobility  Surface charge of particle can be determined by measuring particle velocity in electrical field.  Laser Doppler Anemometry technique for determination of nanoparticles velocity.  Surface charge is also measured as electrical mobility.  Charged composition critically decides bio-distribution of nanoparticle.  Zeta potential can also be obtain by measuring the electron mobility. 52
  • 53. 7. Surface hydrophobicity Important influence in interaction of nanoparticles with biological environment. Several methods have been used 1. Hydrophobic interaction chromatography. 2. Two phase partition 3. Contact angle measurement. 53
  • 54. 8. in-vitro release  in-vitro release studies are done by: 1. Diffusion cell 2. Ultra- filteration technique 54
  • 56. 10. Drug entrapment efficiency 56
  • 57. 57